GSK1940029 (SCD inhibitor 1) is astearoyl-coa desaturase(SCD) inhibitor extracted from patent WO/2009060053 A1, compound example 16.

Stearoyl-CoA Desaturase (SCD)^[1]

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease^[1].

391.25

Solid

C₁₈H₁₆Cl₂N₄O₂

1150701-66-8

Room temperature in continental US; may vary elsewhere.

DMSO : ≥ 32 mg/mL(81.79 mM)

*"≥" means soluble, but saturation unknown.

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。